Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Ashcroft

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Annals of Hematology|November 25, 2018
Navigating the treatment landscape in multiple myeloma: which combinations to use and when?Hartmut Goldschmidt, John Ashcroft, Zsolt Szabo, et al.
International Journal of Hematologic Oncology|October 11, 2018
Chart review across EU5 in MM post-ASCT patientsJohn Ashcroft, Davneet Judge, Sujith Dhanasiri, et al.
Clinical Lymphoma & Myeloma|April 14, 2009
Assessment of bone marrow response in Waldenström's macroglobulinemiaAbraham M Varghese, Andy C Rawstron, A John Ashcroft, et al.
Frontiers in Oncology|March 13, 2023
Benefits of switching from intravenous to subcutaneous daratumumab: Perspectives from UK healthcare providersGordon Cook, John Ashcroft, Mariana Fernandez, et al.
European Journal of Haematology|February 15, 2018
Healthcare resource utilisation associated with skeletal-related events in European patients with multiple myeloma: Results from a prospective, multinational, observational studyJohn Ashcroft, Ignacio Duran, Herbert Hoefeler, et al.
British Journal of Haematology|February 23, 2024
Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice PaperDaniel Hughes, Kwee Yong, Karthik Ramasamy, et al.
Molecular and Clinical Oncology|July 24, 2014
Health resource utilisation associated with skeletal-related events in European patients with lung cancer: Α subgroup analysis from a prospective multinational studyVito Lorusso, Ignacio Duran, Cristina Garzon-Rodriguez, et al.
Leukemia & Lymphoma|August 18, 2011
Survival of patients with hematological malignancy admitted to the intensive care unit: prognostic factors and outcome compared to unselected medical intensive care unit admissions, a parallel group studyQuentin A Hill, Richard J Kelly, Chetan Patalappa, et al.
Journal of Clinical Medicine|August 4, 2015
Health Resource Utilization Associated with Skeletal-Related Events in Patients with Advanced Prostate Cancer: A European Subgroup Analysis from an Observational, Multinational StudyAmit Bahl, Herbert Hoefeler, Ignacio Duran, et al.
Springerplus|July 22, 2014
Health resource utilization associated with skeletal-related events in patients with advanced breast cancer: results from a prospective, multinational observational studyDiana Lüftner, Vito Lorusso, Ignacio Duran, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Annals of Hematology|November 25, 2018
Navigating the treatment landscape in multiple myeloma: which combinations to use and when?Hartmut Goldschmidt, John Ashcroft, Zsolt Szabo, et al.
International Journal of Hematologic Oncology|October 11, 2018
Chart review across EU5 in MM post-ASCT patientsJohn Ashcroft, Davneet Judge, Sujith Dhanasiri, et al.
Clinical Lymphoma & Myeloma|April 14, 2009
Assessment of bone marrow response in Waldenström's macroglobulinemiaAbraham M Varghese, Andy C Rawstron, A John Ashcroft, et al.
Frontiers in Oncology|March 13, 2023
Benefits of switching from intravenous to subcutaneous daratumumab: Perspectives from UK healthcare providersGordon Cook, John Ashcroft, Mariana Fernandez, et al.
European Journal of Haematology|February 15, 2018
Healthcare resource utilisation associated with skeletal-related events in European patients with multiple myeloma: Results from a prospective, multinational, observational studyJohn Ashcroft, Ignacio Duran, Herbert Hoefeler, et al.
British Journal of Haematology|February 23, 2024
Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice PaperDaniel Hughes, Kwee Yong, Karthik Ramasamy, et al.
Molecular and Clinical Oncology|July 24, 2014
Health resource utilisation associated with skeletal-related events in European patients with lung cancer: Α subgroup analysis from a prospective multinational studyVito Lorusso, Ignacio Duran, Cristina Garzon-Rodriguez, et al.
Leukemia & Lymphoma|August 18, 2011
Survival of patients with hematological malignancy admitted to the intensive care unit: prognostic factors and outcome compared to unselected medical intensive care unit admissions, a parallel group studyQuentin A Hill, Richard J Kelly, Chetan Patalappa, et al.
Journal of Clinical Medicine|August 4, 2015
Health Resource Utilization Associated with Skeletal-Related Events in Patients with Advanced Prostate Cancer: A European Subgroup Analysis from an Observational, Multinational StudyAmit Bahl, Herbert Hoefeler, Ignacio Duran, et al.
Springerplus|July 22, 2014
Health resource utilization associated with skeletal-related events in patients with advanced breast cancer: results from a prospective, multinational observational studyDiana Lüftner, Vito Lorusso, Ignacio Duran, et al.
Pageof 4